Clinical trial
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
NCT00006088 · H. Lee Moffitt Cancer Center and Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00006088 |
|---|---|
| Title | Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors |
| Official title | A Phase I Absolute Bioavailability Study of Oral NAVELBINE (Vinorelbine Tartrate) in Patients With Solid Tumors |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | vinorelbine tartrate |
| Start date | Jun 1, 2000 |
| First posted | Jun 22, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: